In metastatic tumors, the prevalence of TMPRSS2-ETS fusions did not differ by tumor BRCA2 status, nor did the prevalence of TMPRSS2-ERG, TMPRSS2-intragenic or other SVs involving ETS family genes. Here, BRCA2 is linked to metastatic neoplasm.